Related Experiment Videos

Ursolic acid inhibits early lesions of diabetic nephropathy

Yi Zhou1, Jian-Shuang Li, Xin Zhang

  • 1College of Life Sciences, Wuhan University, Wuhan, P.R. China.

International Journal of Molecular Medicine
|September 7, 2010
PubMed

Insights

Ursolic acid (UA) significantly reduces early kidney damage in diabetic nephropathy (DN) by ameliorating glomerular hypertrophy and collagen accumulation. This natural compound also modulates key signaling pathways involved in DN progression.

Area of Science:

  • Nephrology
  • Pharmacology
  • Diabetology

Background:

  • Diabetic nephropathy (DN) is a major complication of diabetes, characterized by early lesions like glomerular hypertrophy and type IV collagen accumulation.
  • Identifying effective therapeutic agents to prevent or treat DN is crucial for managing diabetic patients.

Purpose of the Study:

  • To investigate the therapeutic potential of ursolic acid (UA) in mitigating the development of early diabetic nephropathy lesions.
  • To explore the molecular mechanisms underlying UA's effects on diabetic kidney disease.

Main Methods:

  • Streptozotocin (STZ)-induced diabetic mice were treated with low-dose ursolic acid (0.01% in food) for three months.
  • Kidney tissues were analyzed for glomerular hypertrophy and type IV collagen accumulation.
  • Key signaling pathways (STAT-3, ERK1/2, JNK, p38) and iNOS expression were assessed.

Main Results:

  • Ursolic acid treatment markedly ameliorated diabetes-induced glomerular hypertrophy and type IV collagen accumulation in the kidneys.
  • UA suppressed the activation of STAT-3, ERK1/2, and JNK signaling pathways, but not the p38 pathway.
  • Overexpression of inducible nitric oxide synthase (iNOS) in the renal cortex was significantly reduced by UA treatment.

Conclusions:

  • Ursolic acid demonstrates significant protective effects against early kidney damage in a mouse model of diabetic nephropathy.
  • UA's therapeutic potential in DN may be attributed to its ability to modulate specific intracellular signaling pathways and reduce iNOS expression.
  • Ursolic acid is a promising candidate for further development as a therapeutic agent for diabetic nephropathy.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...